{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:12:11Z","timestamp":1784542331906,"version":"3.55.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.kint.2026.02.042","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:21:55Z","timestamp":1778552515000},"page":"318-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tubulointerstitial diseases: an updated framework for diverse and emerging entities"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-2863","authenticated-orcid":false,"given":"Lynn D.","family":"Cornell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.02.042_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ki.2010.342","article-title":"IgG4-related tubulointerstitial nephritis","volume":"78","author":"Cornell","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-related disease","volume":"392","author":"Stone","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MNH.0000000000000790","article-title":"New therapeutics for primary hyperoxaluria type 1","volume":"31","author":"Dejban","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2026.02.042_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ackd.2016.08.003","article-title":"Clinical approach to diagnosing acute and chronic tubulointerstitial disease","volume":"24","author":"Perazella","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.34067\/KID.0001742021","article-title":"The challenges of acute interstitial nephritis: time to standardize","volume":"2","author":"Moledina","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2026.02.042_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ki.2014.294","article-title":"Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly","volume":"87","author":"Muriithi","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10157-025-02685-w","article-title":"Clinicopathological findings of tubulointerstitial nephritis: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR)","volume":"29","author":"Oda","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10157-021-02178-6","article-title":"Tubulointerstitial nephritis: a biopsy case series of 139 Japanese patients","volume":"26","author":"Nakaosa","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib10","series-title":"Beitr\u00e4ge zur Chirurgie. Festschrift, gewidmet Theodor Billroth von seinen dankbaren Sch\u00fclern zur Feier des vollendeten 50. Semesters seines akademischen Wirkens in Wien","first-page":"610","article-title":"\u00dcber eine eigenartige symmetrische Erkrankung der Tr\u00e4nen und Mundspeicheldr\u00fcsen","author":"Mikulicz","year":"1892"},{"key":"10.1016\/j.kint.2026.02.042_bib161","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF02232341","article-title":"Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?","volume":"6","author":"Sarles","year":"1961","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2559.2005.02204.x","article-title":"Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera","volume":"47","author":"Aoki","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.kint.2026.02.042_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.kint.2026.02.042_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/PAS.0b013e318059b87c","article-title":"Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease","volume":"31","author":"Cornell","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2026.02.042_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/PAP.0000000000000034","article-title":"Renal pathology associated with hematopoietic stem cell transplantation","volume":"21","author":"Troxell","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993-2011: a case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.01330213","article-title":"Utility of urine eosinophils in the diagnosis of acute interstitial nephritis","volume":"8","author":"Muriithi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","article-title":"Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology","volume":"107","author":"Herrmann","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tox.2005.07.009","article-title":"In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine","volume":"215","author":"Oktem","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.kint.2026.02.042_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2016080867","article-title":"Vancomycin-associated cast nephropathy","volume":"28","author":"Luque","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295136","article-title":"Vancomycin nephrotoxicity: a comprehensive clinico-pathological study","volume":"19","author":"Nachiappa Ganesh","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2026.02.042_bib27","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.ekir.2021.09.003","article-title":"The crystalline nephropathies","volume":"6","author":"Perazella","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib28","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.ekir.2022.09.002","article-title":"Increased rates of supplement-associated oxalate nephropathy during COVID-19 pandemic","volume":"7","author":"Fong","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.mayocp.2023.08.014","article-title":"Clinicopathologic characteristics, etiologies, and outcome of secondary oxalate nephropathy","volume":"99","author":"Nasr","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.kint.2026.02.042_bib30","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1681\/ASN.2005050496","article-title":"Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure","volume":"16","author":"Markowitz","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.humpath.2003.12.005","article-title":"Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing","volume":"35","author":"Markowitz","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.kint.2016.05.006","article-title":"Phosphate enemas and GFR decline: it's premature to sound the alarm","volume":"90","author":"Markowitz","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/j.ajkd.2015.11.018","article-title":"Estimated GFR decline following sodium phosphate enemas versus polyethylene glycol for screening colonoscopy: a retrospective cohort study","volume":"67","author":"Schaefer","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib34","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ekir.2023.04.014","article-title":"Clinical outcomes in patients with biopsy proven anticoagulant-related nephropathy","volume":"8","author":"Dasgupta","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2022.01.1048","article-title":"IgA nephropathy is the most common underlying disease in patients with anticoagulant-related nephropathy","volume":"7","author":"Trujillo","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.xkme.2019.03.002","article-title":"Anticoagulant-related nephropathy in kidney biopsy: a single-center report of 41 cases","volume":"1","author":"Brodsky","year":"2019","journal-title":"Kidney Med"},{"key":"10.1016\/j.kint.2026.02.042_bib37","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.34067\/KID.0005442022","article-title":"Heme proteins and kidney injury: beyond rhabdomyolysis","volume":"3","author":"Nath","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2026.02.042_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ckj\/sfz183","article-title":"Ifosfamide nephrotoxicity in adult patients","volume":"13","author":"Ensergueix","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.02.042_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PAP.0000000000000122","article-title":"Antineoplastic treatment and renal injury: an update on renal pathology due to cytotoxic and targeted therapies","volume":"23","author":"Troxell","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.ajkd.2013.11.028","article-title":"Chronic Ifosfamide toxicity: kidney pathology and pathophysiology","volume":"63","author":"Akilesh","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","article-title":"Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy","volume":"11","author":"Markowitz","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.ajkd.2011.04.030","article-title":"Kidney tubular toxicity of maintenance pemetrexed therapy","volume":"58","author":"Glezerman","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.kint.2020.01.018","article-title":"The spectrum of kidney biopsy findings in HIV-infected patients in the modern era","volume":"97","author":"Kudose","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib45","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/ndt\/gfae184","article-title":"Immune checkpoint inhibitor-associated nephritis-treatment standard","volume":"39","author":"Barbir","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182275","article-title":"F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury","volume":"134","author":"Gupta","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2026.02.042_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1681\/ASN.2019070676","article-title":"Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study","volume":"31","author":"Cortazar","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib49","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1038\/s41598-025-88713-x","article-title":"Global burden of vaccine-associated kidney injury using an international pharmacovigilance database","volume":"15","author":"Hwang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000523962","article-title":"New onset biopsy-proven nephropathies after COVID vaccination","volume":"53","author":"Fenoglio","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.kint.2021.06.002","article-title":"Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine","volume":"100","author":"Masset","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ckj\/sfab180","article-title":"Acute interstitial nephritis after messenger RNA-based vaccination","volume":"15","author":"Czerlau","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.02.042_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2008.09.015","article-title":"Giant cell tubulitis with immune complex deposits in a patient with lupus nephritis","volume":"53","author":"Hodgin","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib54","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.02201205","article-title":"Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgery","volume":"1","author":"Chang","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAT.0b013e3283468772","article-title":"Giant cell tubulitis and tubular basement membrane immune deposits","volume":"43","author":"Lee","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.kint.2026.02.042_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/106689690601400110","article-title":"Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution","volume":"14","author":"Bijol","year":"2006","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ckj\/sfv071","article-title":"Etiological diagnosis of granulomatous tubulointerstitial nephritis in the tropics","volume":"8","author":"Agrawal","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.02.042_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anndiagpath.2015.03.003","article-title":"Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"19","author":"Nasr","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.0000000000000193","article-title":"Clinical and prognostic factors in patients with IgG4-related kidney disease","volume":"18","author":"Chaba","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.semdp.2023.12.001","article-title":"IgG4-related kidney disease: clinicopathologic features, differential diagnosis, and mimics","volume":"41","author":"Gilani","year":"2024","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ekir.2018.08.011","article-title":"Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort","volume":"4","author":"Evans","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib62","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ekir.2024.05.011","article-title":"Clinicopathologic features of IgG4-related kidney disease","volume":"9","author":"Buglioni","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib63","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1681\/ASN.2016101074","article-title":"Tubulointerstitial nephritis with IgM-positive plasma cells","volume":"28","author":"Takahashi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib64","article-title":"Long-term outcomes of IgM-positive plasma cell tubulointerstitial nephritis","volume":"11","author":"Takahashi","year":"2026","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ekir.2022.09.019","article-title":"Clinicopathologic findings in mass forming ANCA-associated vasculitis","volume":"7","author":"Gilani","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.kint.2026.02.042_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAS.0000000000000575","article-title":"Multicentric Castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease: two case reports","volume":"40","author":"Zoshima","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib68","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2169\/internalmedicine.51.7970","article-title":"IgG4-associated tubulointerstitial nephritis: two case reports and a literature review","volume":"51","author":"Fang","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.kint.2026.02.042_bib69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CN108621","article-title":"Report of six kidney disease-associated Castleman's disease cases","volume":"84","author":"Sui","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.34067\/KID.0000432020","article-title":"Renal manifestations of common variable immunodeficiency","volume":"1","author":"Caza","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2026.02.042_bib71","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/ckj\/sfaa276","article-title":"The histopathological spectrum of kidney biopsies in patients with thymoma and myasthenia gravis: a report of 24 biopsies from a single institution","volume":"14","author":"Takahashi","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2026.02.042_bib72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1681\/ASN.2015030334","article-title":"Immune complex tubulointerstitial nephritis due to autoantibodies to the proximal tubule brush border","volume":"27","author":"Rosales","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100841","article-title":"Antibrush border antibody disease: a case series","volume":"6","author":"Pengshung","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.kint.2026.02.042_bib74","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.kint.2022.02.021","article-title":"Cubilin and amnionless protein are novel target antigens in anti-brush border antibody disease","volume":"101","author":"Morelle","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib75","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1681\/ASN.2017060664","article-title":"LDL receptor-related protein 2 (megalin) as a target antigen in human kidney anti-brush border antibody disease","volume":"29","author":"Larsen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib76","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ekir.2023.11.008","article-title":"Clinicopathologic features of antibrush border antibody disease","volume":"9","author":"Murphy","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.ajkd.2018.12.039","article-title":"Anti-LRP2 nephropathy with abundant IgG4-positive plasma cells: a case report","volume":"74","author":"Dinesh","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib78","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ekir.2023.02.1093","article-title":"DNAJB9-positive tubulointerstitial-predominant fibrillary nephritis","volume":"8","author":"Bourhis","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib79","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib81","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib82","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.xkme.2021.04.014","article-title":"Genomics integration into nephrology practice","volume":"3","author":"Pinto","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.kint.2026.02.042_bib83","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2014A KDIGO consensus report","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib84","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2026.02.042_bib85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5414\/CNP74411","article-title":"Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone","volume":"74","author":"Bleyer","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib86","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.kint.2025.08.033","article-title":"Mono-allelic pathogenic variants in JAG1 cause autosomal dominant tubulo-interstitial kidney disease (ADTKD-JAG1)","volume":"109","author":"Menguy","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ki.2014.72","article-title":"Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin","volume":"86","author":"Ekici","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib88","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.ki.5002679","article-title":"Uromodulin storage disease","volume":"73","author":"Nasr","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib89","first-page":"2080","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Bleyer","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib90","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.kint.2023.11.021","article-title":"Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis","volume":"105","author":"Kmochova","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib91","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ki.2014.389","article-title":"Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis","volume":"87","author":"Gregorini","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib92","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.kint.2016.04.003","article-title":"Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis","volume":"90","author":"Dasari","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib93","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.kint.2024.01.025","article-title":"Autosomal dominant chronic tubulointerstitial nephropathy: do not forget amyloidosis","volume":"105","author":"Bridoux","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib94","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng.2347","article-title":"FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair","volume":"44","author":"Zhou","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2026.02.042_bib95","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.kint.2026.01.001","article-title":"Genotype-phenotype characteristics and disease progression of FAN1-related karyomegalic tubulointerstitial nephropathy","volume":"109","author":"Clince","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2018.06.021","article-title":"Fluorescence in situ hybridization for the diagnosis of NPHP1 deletion-related nephronophthisis on renal biopsy","volume":"81","author":"Larsen","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib97","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ekir.2023.03.012","article-title":"The site and type of CLCN5 genetic variation impact the resulting Dent disease-1 phenotype","volume":"8","author":"Arnous","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib98","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2215\/CJN.03710416","article-title":"Glomerular pathology in dent disease and its association with kidney function","volume":"11","author":"Wang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib99","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-physiol-042222-025000","article-title":"Mitochondrial dysfunction in kidney tubulopathies","volume":"86","author":"Hoogstraten","year":"2024","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.kint.2026.02.042_bib100","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.ekir.2021.05.042","article-title":"Mitochondriopathy manifesting as inherited tubulointerstitial nephropathy without symptomatic other organ involvement","volume":"6","author":"Buglioni","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib101","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.ajkd.2018.06.032","article-title":"CKD due to a novel mitochondrial DNA mutation: a case report","volume":"73","author":"Fervenza","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib102","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.ekir.2021.07.003","article-title":"Another case of mitochondriopathy manifesting as inherited tubulointerstitial nephropathy without other symptomatic organ involvement","volume":"6","author":"Gillion","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib103","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ekir.2020.09.044","article-title":"Mitochondrial disease and the kidney with a special focus on CoQ(10) deficiency","volume":"5","author":"Schijvens","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2021050596","article-title":"Gitelman-like syndrome caused by pathogenic variants in mtDNA","volume":"33","author":"Viering","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00467-011-2096-2","article-title":"A mitochondrial DNA deletion presenting with corneal clouding and severe Fanconi syndrome","volume":"27","author":"Lee","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s10038-021-00984-0","article-title":"BCS1L mutations produce Fanconi syndrome with developmental disability","volume":"67","author":"Kanako","year":"2022","journal-title":"J Hum Genet"},{"key":"10.1016\/j.kint.2026.02.042_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1650","article-title":"Novel SARS2 variants identified in a Chinese girl with HUPRA syndrome","volume":"9","author":"Zhou","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.kint.2026.02.042_bib108","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib109","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0000000000001068","article-title":"VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation","volume":"37","author":"Kotter","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2026.02.042_bib110","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/rheumatology\/keae465","article-title":"Acute kidney injury, an underrecognized feature of VEXAS syndrome","volume":"64","author":"Kalantari","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2026.02.042_bib111","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00467-015-3102-x","article-title":"Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder","volume":"30","author":"Sheikine","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib112","article-title":"Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy","volume":"2010","author":"Al-Owain","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.kint.2026.02.042_bib113","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/ndt\/gfae117","article-title":"Primary immunodeficiency as a cause of immune-mediated kidney diseases","volume":"39","author":"Zhang","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fped.2020.00042","article-title":"Case report: exome sequencing reveals LRBA deficiency in a patient with end-stage renal disease","volume":"8","author":"Taylan","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.kint.2026.02.042_bib115","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ekir.2018.07.020","article-title":"Secondary oxalate nephropathy: a systematic review","volume":"3","author":"Lumlertgul","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib116","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2215\/CJN.00010111","article-title":"Oxalate nephropathy associated with chronic pancreatitis","volume":"6","author":"Cartery","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib117","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.02940608","article-title":"Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure","volume":"3","author":"Nasr","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib118","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.semdp.2020.02.001","article-title":"A practical approach to the pathology of renal intratubular casts","volume":"37","author":"Dvanajscak","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib120","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.kint.2019.08.026","article-title":"Hemolysis-associated hemoglobin cast nephropathy results from a range of clinicopathologic disorders","volume":"96","author":"Dvanajscak","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.semdp.2020.02.002","article-title":"A diagnostician's field guide to crystalline nephropathies","volume":"37","author":"Nicholas Cossey","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib122","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ekir.2023.05.007","article-title":"Clinicopathologic spectrum of lysozyme-associated nephropathy","volume":"8","author":"Kudose","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib162","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ekir.2019.04.025","article-title":"Chromogranin A tubulopathy: differing histopathologic patterns of acute tubular injury in the setting of neuroendocrine neoplasms","volume":"4","author":"Sekulic","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib123","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ndt\/gfw346","article-title":"Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants","volume":"32","author":"Jayasumana","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib124","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.kint.2019.11.009","article-title":"Chronic interstitial nephritis in agricultural communities is a toxin-induced proximal tubular nephropathy","volume":"97","author":"Vervaet","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.113119","article-title":"Low-level exposure to lead, cadmium and mercury, and histopathological findings in kidney biopsies","volume":"211","author":"Barregard","year":"2022","journal-title":"Environ Res"},{"key":"10.1016\/j.kint.2026.02.042_bib126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1039\/D4VA00304G","article-title":"A critical review of a hidden epidemic: examining the occupational and environmental risk factors of chronic kidney disease of unknown etiology (CKDu)","volume":"4","author":"Bradley","year":"2025","journal-title":"Environ Sci Adv"},{"key":"10.1016\/j.kint.2026.02.042_bib127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0971-4065.145095","article-title":"Endemic chronic kidney disease of unknown etiology in Sri Lanka: correlation of pathology with clinical stages","volume":"25","author":"Wijetunge","year":"2015","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.ajkd.2013.05.019","article-title":"Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America","volume":"62","author":"Wijkstrom","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib129","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib130","series-title":"GeneReviews\u00ae","article-title":"Primary hyperoxaluria type 1","author":"Milliner","year":"1993"},{"key":"10.1016\/j.kint.2026.02.042_bib131","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.02.042_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102437","article-title":"Development, opportunities, and challenges of siRNA nucleic acid drugs","volume":"36","author":"Xiao","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.kint.2026.02.042_bib133","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/gfp711","article-title":"Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure","volume":"25","author":"Nasr","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib134","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.ki.5002730","article-title":"Infantile nephropathic cystinosis","volume":"73","author":"Stokes","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.kint.2022.10.025","article-title":"The pathologic spectrum of adenovirus nephritis in the kidney allograft","volume":"103","author":"Jagannathan","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.3.4-5.393","article-title":"Acute interstitial nephritis","volume":"3","author":"Councilman","year":"1898","journal-title":"J Exp Med"},{"key":"10.1016\/j.kint.2026.02.042_bib137","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.mayocp.2021.07.001","article-title":"Acute kidney injury in severe COVID-19 has similarities to sepsis-associated kidney injury: a multi-omics study","volume":"96","author":"Alexander","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.kint.2026.02.042_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102535","article-title":"Risk of acute kidney injury in critically-ill patients with COVID-19 compared with seasonal influenza: a retrospective cohort study","volume":"70","author":"Ng","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.kint.2026.02.042_bib139","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2215\/CJN.04560421","article-title":"Evidence for and against direct kidney infection by SARS-CoV-2 in patients with COVID-19","volume":"16","author":"Hassler","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000513789","article-title":"The COVID-kidney controversy: can SARS-CoV-2 cause direct renal infection?","volume":"145","author":"Lau","year":"2021","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2026.02.042_bib141","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajpath.2020.11.003","article-title":"Characterizing viral infection by electron microscopy: lessons from the coronavirus disease 2019 pandemic","volume":"191","author":"Akilesh","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib142","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1600-6143.2007.01794.x","article-title":"Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy","volume":"7","author":"Bracamonte","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib143","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.kint.2023.02.028","article-title":"Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children","volume":"103","author":"Avramescu","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib144","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2010.12.010","article-title":"Diffuse infiltrative lymphocytosis syndrome presenting as reversible acute kidney injury associated with Gram-negative bacterial infection in patients with newly diagnosed HIV infection","volume":"57","author":"Yoo","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.02.042_bib145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","article-title":"Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib146","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ekir.2025.03.052","article-title":"Spectrum of kidney pathology in patients with syphilis","volume":"10","author":"Fang","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib147","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.kint.2025.04.007","article-title":"Renal Pathology Society\/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions","volume":"108","author":"Nasr","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib148","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib149","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ki.2010.9","article-title":"Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies","volume":"77","author":"Larsen","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.3163","article-title":"Of men, not mice","volume":"19","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2026.02.042_bib152","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajt.2023.11.008","article-title":"Exploring the single-cell immune landscape of kidney allograft inflammation using imaging mass cytometry","volume":"24","author":"Alexander","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2026.02.042_bib153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41581-019-0227-3","article-title":"Using single-cell technologies to map the human immune system\u2014implications for nephrology","volume":"16","author":"Stewart","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.02.042_bib154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajpath.2024.06.012","article-title":"Spatial transcriptomics: integrating morphology and molecular mechanisms of kidney diseases","volume":"195","author":"Isnard","year":"2025","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2026.02.042_bib155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.kint.2021.08.033","article-title":"Highly multiplexed immunofluorescence of the human kidney using co-detection by indexing","volume":"101","author":"Neumann","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.02.042_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1744430","article-title":"Capturing the inflammatory landscape within kidney compartments of human diabetic kidney disease: a digital spatial profiling study","volume":"17","author":"Elhusseiny","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2026.02.042_bib157","article-title":"Spatial transcriptomics identify T cell-driven mechanisms of kidney damage in immune checkpoint inhibitor-associated acute interstitial nephritis","author":"Qin","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.kint.2026.02.042_bib158","first-page":"523","article-title":"Ontology-based modeling, integration, and analysis of heterogeneous clinical, pathological, and molecular kidney data for precision medicine","volume":"2024","author":"He","year":"2025","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.kint.2026.02.042_bib159","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ekir.2025.05.035","article-title":"Chronic changes on kidney histology by a multiclass artificial intelligence model","volume":"10","author":"Denic","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.02.042_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11783","article-title":"Banff Digital Pathology Working Group: image bank, artificial intelligence algorithm, and challenge trial developments","volume":"36","author":"Farris","year":"2023","journal-title":"Transpl Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:59:55Z","timestamp":1784541595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0085253826003261"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.02.042","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tubulointerstitial diseases: an updated framework for diverse and emerging entities","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}